Cardinal Health (NYSE:CAH) CEO Stephen Mason Sells 35,000 Shares

Cardinal Health, Inc. (NYSE:CAH) CEO Stephen Mason sold 35,000 shares of the stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $236.40, for a total value of $8,274,000.00. Following the completion of the transaction, the chief executive officer directly owned 18,061 shares of the company’s stock, valued at approximately $4,269,620.40. The trade was a 65.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.

Cardinal Health Price Performance

Shares of CAH stock opened at $228.95 on Friday. The stock’s fifty day simple moving average is $231.91 and its 200 day simple moving average is $217.78. Cardinal Health, Inc. has a one year low of $145.87 and a one year high of $258.30. The firm has a market cap of $53.25 billion, a price-to-earnings ratio of 31.67, a P/E/G ratio of 1.26 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.42 by $0.49. The firm had revenue of $63.67 billion during the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the prior year, the company posted $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, research analysts anticipate that Cardinal Health, Inc. will post 12.54 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be given a dividend of $0.5158 per share. The ex-dividend date is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is 28.49%.

Analysts Set New Price Targets

CAH has been the topic of several research analyst reports. Barclays upped their price objective on shares of Cardinal Health from $258.00 to $275.00 and gave the stock an “overweight” rating in a research note on Thursday, August 13th. UBS Group raised their price target on Cardinal Health from $274.00 to $280.00 and gave the company a “buy” rating in a report on Wednesday, August 12th. Evercore reissued an “outperform” rating and issued a $270.00 price objective on shares of Cardinal Health in a research note on Wednesday, August 12th. William Blair assumed coverage on Cardinal Health in a report on Tuesday, April 28th. They set an “outperform” rating on the stock. Finally, Citigroup increased their target price on Cardinal Health from $265.00 to $280.00 and gave the stock a “buy” rating in a report on Wednesday, August 12th. Sixteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus target price of $266.56.

Institutional Trading of Cardinal Health

Several hedge funds have recently modified their holdings of CAH. Investors Research Corp bought a new position in Cardinal Health in the 2nd quarter worth approximately $29,000. University of Texas Texas AM Investment Management Co. bought a new position in Cardinal Health in the 4th quarter valued at $26,000. Allied Private Wealth LLC bought a new position in Cardinal Health in the 2nd quarter valued at $30,000. Bank of Jackson Hole Trust acquired a new stake in shares of Cardinal Health in the 4th quarter valued at $27,000. Finally, Indiana Trust & Investment Management Co acquired a new stake in shares of Cardinal Health in the 1st quarter valued at $29,000. 87.17% of the stock is owned by institutional investors.

Trending Headlines about Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Royal Bank of Canada initiated coverage of Cardinal Health with a “moderate buy” or outperform-equivalent rating. RBC cited the integration of higher-margin services as a potential driver of future earnings outperformance. RBC Capital Starts Cardinal Health at Outperform
• Positive Sentiment: A Zacks analysis identified CAH as a potentially attractive long-term value stock, while recent coverage has highlighted Cardinal Health’s precision-medicine operations and higher-margin services as sources of sustained growth. Why Cardinal Health Is a Top Value Stock for the Long-Term
• Neutral Sentiment: Brokerages continue to assign Cardinal Health a consensus “moderate buy” rating. The constructive view is tempered by valuation and questions about the sustainability of recent earnings gains.
• Negative Sentiment: Multiple executives and insiders sold shares around $235–$237. Chief Executive Officer Jason Hollar sold a combined 124,529 shares worth approximately $29.4 million, while CEO Deborah Weitzman sold about $1.7 million. Other insider sales included Chief Accounting Officer Mary Scherer and executives Michelle Greene, Jessica Mayer, and Stephen Mason. The transactions substantially reduced several executives’ holdings and may signal that insiders are taking profits after the stock’s strong rally. Cardinal Health Insider Sale Filing
• Negative Sentiment: Although Cardinal Health reported adjusted quarterly EPS of $2.91, well above the $2.42 consensus, an analysis noted that a significant portion of the earnings improvement came from a one-time tariff refund. That raises concerns about the durability of the earnings beat and may be contributing to the weaker stock performance. Cardinal Health Earnings Analysis

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.